Manulife (Manufacturers Life Insurance)’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.24M Sell
94,801
-26,049
-22% -$1.44M ﹤0.01% 1141
2025
Q1
$5.84M Sell
120,850
-3,491
-3% -$169K 0.01% 1101
2024
Q4
$4.8M Buy
124,341
+8,576
+7% +$331K ﹤0.01% 1230
2024
Q3
$5.21M Buy
115,765
+1,359
+1% +$61.2K ﹤0.01% 1199
2024
Q2
$3.96M Buy
114,406
+24,749
+28% +$858K ﹤0.01% 1260
2024
Q1
$2.59M Buy
89,657
+21,225
+31% +$614K ﹤0.01% 1429
2023
Q4
$1.57M Sell
68,432
-5,691
-8% -$130K ﹤0.01% 1563
2023
Q3
$1.24M Buy
74,123
+8,231
+12% +$137K ﹤0.01% 1625
2023
Q2
$1.82M Buy
65,892
+21,037
+47% +$581K ﹤0.01% 1436
2023
Q1
$1.03M Buy
44,855
+26,337
+142% +$606K ﹤0.01% 1621
2022
Q4
$202K Sell
18,518
-54
-0.3% -$589 ﹤0.01% 2574
2022
Q3
$157K Sell
18,572
-816
-4% -$6.88K ﹤0.01% 2687
2022
Q2
$153K Sell
19,388
-20,987
-52% -$166K ﹤0.01% 2780
2022
Q1
$961K Buy
40,375
+17,553
+77% +$418K ﹤0.01% 1776
2021
Q4
$781 Sell
22,822
-759
-3% -$26 ﹤0.01% 1989
2021
Q3
$418K Buy
23,581
+556
+2% +$9.86K ﹤0.01% 2425
2021
Q2
$1.03M Buy
23,025
+2,986
+15% +$134K ﹤0.01% 1976
2021
Q1
$519K Buy
20,039
+1,024
+5% +$26.5K ﹤0.01% 2250
2020
Q4
$383K Buy
19,015
+1,850
+11% +$37.3K ﹤0.01% 2368
2020
Q3
$336K Buy
17,165
+3,490
+26% +$68.3K ﹤0.01% 2213
2020
Q2
$238K Buy
13,675
+1,475
+12% +$25.7K ﹤0.01% 2410
2020
Q1
$86K Buy
12,200
+1,005
+9% +$7.08K ﹤0.01% 2621
2019
Q4
$79K Buy
11,195
+210
+2% +$1.48K ﹤0.01% 2830
2019
Q3
$144K Buy
10,985
+149
+1% +$1.95K ﹤0.01% 2725
2019
Q2
$131K Buy
+10,836
New +$131K ﹤0.01% 2825
2018
Q3
Sell
-581
Closed -$4K 3656
2018
Q2
$4K Sell
581
-8,537
-94% -$58.8K ﹤0.01% 4127
2018
Q1
$78K Sell
9,118
-305
-3% -$2.61K ﹤0.01% 3464
2017
Q4
$196K Buy
9,423
+537
+6% +$11.2K ﹤0.01% 3016
2017
Q3
$158K Buy
8,886
+7,772
+698% +$138K ﹤0.01% 3164
2017
Q2
$13K Sell
1,114
-6,113
-85% -$71.3K ﹤0.01% 3744
2017
Q1
$93K Buy
7,227
+1,481
+26% +$19.1K ﹤0.01% 3212
2016
Q4
$126K Buy
+5,746
New +$126K ﹤0.01% 3106